Net Income (Loss) Attributable to Parent in USD of Entera Bio Ltd. from 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Entera Bio Ltd. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to Q3 2025.
  • Entera Bio Ltd. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$3.2M, a 5.93% decline year-over-year.
  • Entera Bio Ltd. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$10.8M, a 17.5% decline year-over-year.
  • Entera Bio Ltd. annual Net Income (Loss) Attributable to Parent for 2024 was -$9.54M, a 7.34% decline from 2023.
  • Entera Bio Ltd. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.89M, a 32% increase from 2022.
  • Entera Bio Ltd. annual Net Income (Loss) Attributable to Parent for 2022 was -$13.1M, a 7.25% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Entera Bio Ltd. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$10.8M -$3.2M -$179K -5.93% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 -$10.6M -$2.66M -$511K -23.8% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 -$10.1M -$2.57M -$550K -27.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q4 2024 -$9.54M -$2.36M -$363K -18.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 -$9.18M -$3.02M -$642K -27% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 -$8.54M -$2.15M +$180K +7.74% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 -$8.72M -$2.02M +$173K +7.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q4 2023 -$8.89M -$2M +$1.04M +34.3% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-28
Q3 2023 -$9.93M -$2.38M +$688K +22.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$10.6M -$2.33M +$860K +27% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$11.5M -$2.19M +$1.59M +42.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$13.1M -$3.04M +$1.07M +26% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 -$14.1M -$3.07M +$147K +4.57% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$14.3M -$3.19M -$608K -23.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$13.7M -$3.78M -$1.49M -64.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$12.2M -$4.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$3.21M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$2.58M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$2.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12

Entera Bio Ltd. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$9.54M -$652K -7.34% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 -$8.89M +$4.18M +32% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 -$13.1M -$884K -7.25% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 -$12.2M -$971K -8.66% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$11.2M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.